ARCHIVES

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

This article is from The Cancer Letter archive.

Vol. 22 No. 43 | November 8, 1996

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011